Q2 21: strong margins drive big earnings surprise
20/07/21 -"Getinge reported solid Q2 21 numbers. Sales were up 3.6% on an organic basis, driven by 36.5% growth in life science and 1.3% in acute care. As expected, the order book continued to decline (-6.1%) ..."
Pages
63
Language
English
Published on
20/07/21
You may also be interested by these reports :
13/03/26
In addition to a downward revision to our estimates, we have also incorporated a 30% discount to peer-based valuation metrics to account for business ...
12/03/26
We have revised our 2025 figures downward as actuals came in weaker than expected, starting with a 3.5% miss on the top line. We were overly ...
05/03/26
Elekta’s Q3 profitability exceeded consensus expectations. Organic sales growth was recorded in EMEA and APAC, while the Americas exhibited weakness. ...
05/03/26
Amplifon reported another quarterly performance miss, with both sales and profitability falling short of the company-compiled consensus. Although the ...